Research and Markets (http://www.researchandmarkets.com/research/plkjzt/russia_infectious) has announced the addition of the "Russia Infectious Diagnostics Market Outlook to 2021" report to their offering.

"Russia Infectious Diagnostics Market Outlook to 2021" provides key market data on the Russia Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.

- 2014 company shares and distribution shares data for Infectious Diagnostics market.

- Global corporate-level profiles of key companies operating within the Russia Infectious Diagnostics market.

- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc.

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Infectious Diagnostics Market, Russia

4 Overview of Key Companies in Russia, Infectious Diagnostics Market

5 Infectious Diagnostics Market Pipeline Products

6 Financial Deals Landscape

7 Appendix

For more information visit http://www.researchandmarkets.com/research/plkjzt/russia_infectious